Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Herr

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Blood|October 25, 2001
Cellular stress response and apoptosis in cancer therapyI Herr, K M Debatin
Carcinogenesis|June 1, 1994
Binding of promoter-associated AP-1 is not altered during induction and subsequent repression of the c-jun promoter by TPA and UV irradiationI Herr, H van Dam, P Angel
Leukemia|March 23, 1999
Chemotherapeutic drugs sensitize pre-B ALL cells for CD95- and cytotoxic T-lymphocyte-mediated apoptosisC Posovszky, C Friesen, I Herr, et al.
European Journal of Immunology|March 4, 1998
TRAIL/Apo-2-ligand-induced apoptosis in human T cellsI Jeremias, I Herr, T Boehler, et al.
Nucleic Acids Research|January 15, 1997
Cell-type specific DNA-protein interactions at the tissue-type plasminogen activator promoter in human endothelial and HeLa cells in vivo and in vitroJ Arts, I Herr, M Lansink, et al.
Nature Medicine|May 1, 1996
Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cellsC Friesen, I Herr, P H Krammer, et al.
International Journal of Cancer|February 6, 1999
JNK/SAPK activity is not sufficient for anticancer therapy-induced apoptosis involving CD95-L, TRAIL and TNF-alphaI Herr, D Wilhelm, T Böhler, et al.
Cell Death and Differentiation|July 1, 1996
Monitoring of CD95 (APO-1/Fas) ligand expression in human T cells by quantitative RT-PCRI Herr, L Balemans, T Böhler, et al.
The EMBO Journal|October 8, 1997
Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosisI Herr, D Wilhelm, T Böhler, et al.
Cancer Research|September 1, 1997
The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cellsS Fulda, H Sieverts, C Friesen, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Blood|October 25, 2001
Cellular stress response and apoptosis in cancer therapyI Herr, K M Debatin
Carcinogenesis|June 1, 1994
Binding of promoter-associated AP-1 is not altered during induction and subsequent repression of the c-jun promoter by TPA and UV irradiationI Herr, H van Dam, P Angel
Leukemia|March 23, 1999
Chemotherapeutic drugs sensitize pre-B ALL cells for CD95- and cytotoxic T-lymphocyte-mediated apoptosisC Posovszky, C Friesen, I Herr, et al.
European Journal of Immunology|March 4, 1998
TRAIL/Apo-2-ligand-induced apoptosis in human T cellsI Jeremias, I Herr, T Boehler, et al.
Nucleic Acids Research|January 15, 1997
Cell-type specific DNA-protein interactions at the tissue-type plasminogen activator promoter in human endothelial and HeLa cells in vivo and in vitroJ Arts, I Herr, M Lansink, et al.
Nature Medicine|May 1, 1996
Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cellsC Friesen, I Herr, P H Krammer, et al.
International Journal of Cancer|February 6, 1999
JNK/SAPK activity is not sufficient for anticancer therapy-induced apoptosis involving CD95-L, TRAIL and TNF-alphaI Herr, D Wilhelm, T Böhler, et al.
Cell Death and Differentiation|July 1, 1996
Monitoring of CD95 (APO-1/Fas) ligand expression in human T cells by quantitative RT-PCRI Herr, L Balemans, T Böhler, et al.
The EMBO Journal|October 8, 1997
Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosisI Herr, D Wilhelm, T Böhler, et al.
Cancer Research|September 1, 1997
The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cellsS Fulda, H Sieverts, C Friesen, et al.
Pageof 5